165 related articles for article (PubMed ID: 1351849)
41. Differences between the alpha 2-adrenoceptor in rat submaxillary gland and the alpha 2A-and alpha 2B-adrenoceptor subtypes.
Michel AD; Loury DN; Whiting RL
Br J Pharmacol; 1989 Nov; 98(3):890-7. PubMed ID: 2556205
[TBL] [Abstract][Full Text] [Related]
42. The prejunctional inhibitory effect of alpha-methylnoradrenaline in the rat vas deferens is not mediated via alpha 2-adrenoceptors.
Oriowo MA
J Pharm Pharmacol; 1995 Aug; 47(8):661-4. PubMed ID: 8583368
[TBL] [Abstract][Full Text] [Related]
43. Effects of desipramine on prazosin potency at α1A- and α1D-adrenoceptors in rat vas deferens: implications for the α1L-adrenoceptor subclassification.
Docherty JR
Eur J Pharmacol; 2014 Dec; 744():183-9. PubMed ID: 25446564
[TBL] [Abstract][Full Text] [Related]
44. Different subtypes of alpha 1A-adrenoceptor mediating contraction of rat epididymal vas deferens, rat hepatic portal vein and human prostate distinguished by the antagonist RS 17053.
Marshall I; Burt RP; Green GM; Hussain MB; Chapple CR
Br J Pharmacol; 1996 Sep; 119(2):407-15. PubMed ID: 8886428
[TBL] [Abstract][Full Text] [Related]
45. Evidence for pharmacological similarity between alpha 2-adrenoceptors in the vas deferens and central nervous system of the rat.
Doxey JC; Gadie B; Lane AC; Tulloch IF
Br J Pharmacol; 1983 Sep; 80(1):155-61. PubMed ID: 6140052
[TBL] [Abstract][Full Text] [Related]
46. Prazosin has low potency at α1A-adrenoceptors and high potency at α1D -adrenoceptors in rat vas deferens.
Docherty JR
Auton Autacoid Pharmacol; 2013 Oct; 33(3-4):49-57. PubMed ID: 24074250
[TBL] [Abstract][Full Text] [Related]
47. Novel alpha 2-adrenoceptor antagonists show selectivity for alpha 2A- and alpha 2B-adrenoceptor subtypes.
Young P; Berge J; Chapman H; Cawthorne MA
Eur J Pharmacol; 1989 Sep; 168(3):381-6. PubMed ID: 2573535
[TBL] [Abstract][Full Text] [Related]
48. alpha(2)-adrenoceptor antagonist properties of OPC-28326, a novel selective peripheral vasodilator.
Orito K; Kishi M; Imaizumi T; Nakazawa T; Hashimoto A; Mori T; Kambe T
Br J Pharmacol; 2001 Oct; 134(4):763-70. PubMed ID: 11606316
[TBL] [Abstract][Full Text] [Related]
49. "Spare" alpha 1-adrenergic receptors and the potency of agonists in rat vas deferens.
Minneman KP; Abel PW
Mol Pharmacol; 1984 Jan; 25(1):56-63. PubMed ID: 6143249
[TBL] [Abstract][Full Text] [Related]
50. Alpha 2-adrenoceptor binding sites vary along the length of the male reproductive tract: a possible basis for the regional variation in response to field stimulation.
Ventura S; Pennefather JN
Eur J Pharmacol; 1994 Mar; 254(1-2):167-73. PubMed ID: 7911427
[TBL] [Abstract][Full Text] [Related]
51. Pharmacological characterisation of the presynaptic alpha-adrenoceptor in the rat vas deferens.
Drew GM
Eur J Pharmacol; 1977 Mar; 42(2):123-30. PubMed ID: 14838
[TBL] [Abstract][Full Text] [Related]
52. In vivo measurement by [3H]Tamsulosin of alpha1 adrenoceptors in rat tissues in relation to the pharmacokinetics.
Yamada S; Ohkura T; Deguchi Y; Kimura R
J Pharmacol Exp Ther; 1999 Jun; 289(3):1575-83. PubMed ID: 10336555
[TBL] [Abstract][Full Text] [Related]
53. Antagonism by the tetramine disulfide benextramine of the inhibitory effects mediated by prejunctional alpha 2-adrenoceptors and by postjunctional histamine H2 receptors in the mouse vas deferens.
Vohra MM; Chaudhry A
Can J Physiol Pharmacol; 1984 Sep; 62(9):1147-51. PubMed ID: 6149805
[TBL] [Abstract][Full Text] [Related]
54. Pharmacological analysis of the postjunctional alpha-adrenoceptors of the rat anococcygeus muscle and vas deferens.
Adenekan OO; Tayo FM
Arch Int Pharmacodyn Ther; 1985 Jul; 276(1):106-11. PubMed ID: 2996453
[TBL] [Abstract][Full Text] [Related]
55. Pharmacological properties of the cloned alpha 1A/D-adrenoceptor subtype are consistent with the alpha 1A-adrenoceptor characterized in rat cerebral cortex and vas deferens.
Kenny BA; Naylor AM; Greengrass PM; Russell MJ; Friend SJ; Read AM; Wyllie MG
Br J Pharmacol; 1994 Apr; 111(4):1003-8. PubMed ID: 7913370
[TBL] [Abstract][Full Text] [Related]
56. No effect of pertussis toxin on peripheral prejunctional alpha 2-adrenoceptor-mediated responses and on endothelium-dependent relaxations in the rat.
Docherty JR
Br J Pharmacol; 1990 Jun; 100(2):348-52. PubMed ID: 2165838
[TBL] [Abstract][Full Text] [Related]
57. Alpha 2-adrenoceptor subtypes and imidazoline-like binding sites in the rat brain.
Brown CM; MacKinnon AC; McGrath JC; Spedding M; Kilpatrick AT
Br J Pharmacol; 1990 Apr; 99(4):803-9. PubMed ID: 1972896
[TBL] [Abstract][Full Text] [Related]
58. Investigation of the subtypes of alpha1-adrenoceptor mediating contractions of rat vas deferens.
Honner V; Docherty JR
Br J Pharmacol; 1999 Nov; 128(6):1323-31. PubMed ID: 10578148
[TBL] [Abstract][Full Text] [Related]
59. Alpha 1-adrenoceptors and calcium sources in adrenergic neurogenic contractions of rat vas deferens.
Bültmann R; Kurz AK; Starke K
Br J Pharmacol; 1994 Jan; 111(1):151-8. PubMed ID: 7912153
[TBL] [Abstract][Full Text] [Related]
60. Functional and radioligand binding characterization of the α1L-adrenoceptor subtype of the human vas deferens.
Davis BJ; Wiener M; Chapple CR; Sellers DJ; Chess-Williams R
Auton Autacoid Pharmacol; 2015 Apr; 34(3-4):41-9. PubMed ID: 25790239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
